Our interesting finding of CTLA-4 overexpression (but not PD1 or PDL1) in immune cells adjacent to PDAC tumor cells, provides compelling evidence that spatial information might be used to guide immunotherapy selection, but this requires additional investigation. This evidence concerns the gene CTLA4 and neoplasm.